These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 39273272)

  • 41. Hutchinson-Gilford progeria syndrome mice display accelerated arterial thrombus formation and increased platelet reactivity.
    Puspitasari YM; Ministrini S; Han J; Karch C; Prisco F; Liberale L; Bengs S; Akhmedov A; Montecucco F; Beer JH; Lüscher TF; Bongiovanni D; Camici GG
    Thromb Res; 2024 Sep; 241():109100. PubMed ID: 39032390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin.
    Yang SH; Chang SY; Ren S; Wang Y; Andres DA; Spielmann HP; Fong LG; Young SG
    Hum Mol Genet; 2011 Feb; 20(3):436-44. PubMed ID: 21088111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
    Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
    Elife; 2015 Aug; 4():. PubMed ID: 26312502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
    Chen X; Yao H; Andrés V; Bergo MO; Kashif M
    Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular insights into the premature aging disease progeria.
    Vidak S; Foisner R
    Histochem Cell Biol; 2016 Apr; 145(4):401-17. PubMed ID: 26847180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin.
    McClintock D; Ratner D; Lokuge M; Owens DM; Gordon LB; Collins FS; Djabali K
    PLoS One; 2007 Dec; 2(12):e1269. PubMed ID: 18060063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways.
    Clements CS; Bikkul MU; Ofosu W; Eskiw C; Tree D; Makarov E; Kill IR; Bridger JM
    Biogerontology; 2019 Jun; 20(3):337-358. PubMed ID: 31041622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome.
    Halaschek-Wiener J; Brooks-Wilson A
    J Gerontol A Biol Sci Med Sci; 2007 Jan; 62(1):3-8. PubMed ID: 17301031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impairment of nuclear F-actin formation and its relevance to cellular phenotypes in Hutchinson-Gilford progeria syndrome.
    Takahashi Y; Hiratsuka S; Machida N; Takahashi D; Matsushita J; Hozak P; Misteli T; Miyamoto K; Harata M
    Nucleus; 2020 Dec; 11(1):250-263. PubMed ID: 32954953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A-type lamins and Hutchinson-Gilford progeria syndrome: pathogenesis and therapy.
    Gonzalez JM; Pla D; Perez-Sala D; Andres V
    Front Biosci (Schol Ed); 2011 Jun; 3(3):1133-46. PubMed ID: 21622261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
    Rajeev M; Ratan C; Krishnan K; Vijayan M
    Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS.
    Kim BH; Chung YH; Woo TG; Kang SM; Park S; Park BJ
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the Hutchinson-Gilford Progeria Mutation Leads to Aberrant Dentin Formation.
    Choi H; Kim TH; Jeong JK; Strandgren C; Eriksson M; Cho ES
    Sci Rep; 2018 Oct; 8(1):15368. PubMed ID: 30337599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear membrane ruptures underlie the vascular pathology in a mouse model of Hutchinson-Gilford progeria syndrome.
    Kim PH; Chen NY; Heizer PJ; Tu Y; Weston TA; Fong JL; Gill NK; Rowat AC; Young SG; Fong LG
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson-Gilford progeria syndrome.
    Wang M; Wang L; Qian M; Tang X; Liu Z; Lai Y; Ao Y; Huang Y; Meng Y; Shi L; Peng L; Cao X; Wang Z; Qin B; Liu B
    Aging Cell; 2020 Jun; 19(6):e13147. PubMed ID: 32351002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Molecular and Cellular Basis of Hutchinson-Gilford Progeria Syndrome and Potential Treatments.
    Batista NJ; Desai SG; Perez AM; Finkelstein A; Radigan R; Singh M; Landman A; Drittel B; Abramov D; Ahsan M; Cornwell S; Zhang D
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
    Cao K; Graziotto JJ; Blair CD; Mazzulli JR; Erdos MR; Krainc D; Collins FS
    Sci Transl Med; 2011 Jun; 3(89):89ra58. PubMed ID: 21715679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.
    Egesipe AL; Blondel S; Lo Cicero A; Jaskowiak AL; Navarro C; Sandre-Giovannoli A; Levy N; Peschanski M; Nissan X
    NPJ Aging Mech Dis; 2016; 2():16026. PubMed ID: 28721276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progerin in muscle leads to thermogenic and metabolic defects via impaired calcium homeostasis.
    Wang WP; Wang JY; Lin WH; Kao CH; Hung MC; Teng YC; Tsai TF; Chi YH
    Aging Cell; 2020 Feb; 19(2):e13090. PubMed ID: 31833196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS).
    Plasilova M; Chattopadhyay C; Ghosh A; Wenzel F; Demougin P; Noppen C; Schaub N; Szinnai G; Terracciano L; Heinimann K
    PLoS One; 2011; 6(6):e21433. PubMed ID: 21738662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.